Impact of liver-directed therapy and non-therapy on the waiting time list of patient candidates for liver transplantation: retrospective survival analysis

Maria del Pilar Bayona Molano, Lorena Garza, Genaro Selvaggi, Jay Vasani, Juan Carlos Barrera Gutierrez, Jason Salsamendi, Shivank Bhatia, Leopoldo Arosemena

Research output: Contribution to journalArticlepeer-review

Abstract

Aim of the study: To determine whether liver-directed therapies (LDT) and no therapy affect waiting list times for liver transplant candidates from a single center. Material and methods: This retrospective study included patients > 12 years of age diagnosed with hepatocellular carcinoma between January 2014 and June 2019 and followed until the date of transplant, date of delisting, loss to follow-up, or date of death. Waiting list time and associated factors were analyzed using Kaplan-Meier and Cox proportional-hazards methods. Results: A total of 181 patients met the selection criteria. The mean age was 60 years with standard deviation (SD) of 7.8 years. Sixty-six percent underwent transplant, and 64% were classified within the Milan criteria. Men had a lower median waiting list time than women (191 days vs. 236 days, p = 0.0093). The overall median survival time or time to transplant for 50% of the population was 218 days (95% CI: 195-235). Men displayed a 3.1-fold (95% CI: 1.5-6.2) higher probability of transplantation than women (p = 0.002). Patients who received no therapy had a 5-fold higher probability of undergoing transplantation than patients under arterial LDT (HR [95% CI]: 5 [1.2, 20], p = 0.02). Patients under combined LDT displayed a 70% reduced probability of transplantation compared to patients who received arterial LDTs (p = 0.0009). Conclusions: LDT was associated with a prolonged stay on the transplant list, likely due to the presence of an aggressive liver tumor. However, LDTs allow the patient to remain active on the liver transplant list, increasing their chances of undergoing transplantation.

Original languageEnglish (US)
Pages (from-to)304-312
Number of pages9
JournalClinical and Experimental Hepatology
Volume6
Issue number4
DOIs
StatePublished - 2021
Externally publishedYes

Keywords

  • Hepatocellular carcinoma
  • Liver transplant
  • Liver-directed therapies
  • Waiting list time

ASJC Scopus subject areas

  • Hepatology

Fingerprint Dive into the research topics of 'Impact of liver-directed therapy and non-therapy on the waiting time list of patient candidates for liver transplantation: retrospective survival analysis'. Together they form a unique fingerprint.

Cite this